Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Samsung Partners with C2N Diagnostics for Future Growth in Life Science Sector

Mar 13, 2025•over 1 year ago

Contract Type

partnership

St. LouisBiotechnologyHealth Care

Description

Samsung C&T Corporation, Samsung Biologics, Samsung Bioepis, and Samsung Venture Investment Corporation collectively invested $10 million USD in C2N Diagnostics, affirming the value and quality of its advanced diagnostic solutions. This strategic partnership will allow C2N to strengthen its capabilities, expand commercial scale, and innovate next-generation diagnostic tests for improving patients’ lives.

Company Information

Company

C2N Diagnostics

Location

St. Louis, Missouri, United States

About

C2N Diagnostics is a company focused on developing advanced diagnostic solutions in the field of brain health, particularly in the early diagnosis and treatment of Alzheimer's disease.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for C2N Diagnostics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.